These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1906863)

  • 41. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 42. [An in vitro study on combination effect of isepamicin and beta-lactam antibiotics].
    Kumagai K; Otsuki H; Nishibuchi M; Takeda Y
    Jpn J Antibiot; 1990 Sep; 43(9):1579-87. PubMed ID: 2124634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model.
    Xiong YQ; Caillon J; Kergueris MF; Drugeon H; Baron D; Potel G; Bayer AS
    Antimicrob Agents Chemother; 1997 Apr; 41(4):823-6. PubMed ID: 9087497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis.
    Potel G; Caillon J; Le Gallou F; Bugnon D; Le Conte P; Raza J; Lepage JY; Baron D; Drugeon H
    Antimicrob Agents Chemother; 1992 Apr; 36(4):744-50. PubMed ID: 1503436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Once-daily versus thrice-daily administration of netilmicin in combination therapy of Pseudomonas aeruginosa infection in a man-adapted neutropenic animal model.
    Gerber AU; Kozak S; Segessenmann C; Flückiger U; Bangerter T; Greter U
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):233-7. PubMed ID: 2496992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative study of the sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa with 4 aminoglycosides].
    Turgeon P; Lamothe F; Vincelette J; Gaudreau C; Bourgault AM; Turgeon F
    Union Med Can; 1984 Jun; 113(6):522-4. PubMed ID: 6435299
    [No Abstract]   [Full Text] [Related]  

  • 47. [Combined effects of micronomicin and latamoxefi in vitro synergistic activities].
    Kurimoto T; Okachi R
    Jpn J Antibiot; 1983 Jul; 36(7):1599-603. PubMed ID: 6418932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The postantibiotic effect of amikacin alone and in combination with piperacillin on gram-negative bacteria.
    Isaksson B; Hanberger H; Maller R; Nilsson LE; Nilsson M
    Scand J Infect Dis Suppl; 1990; 74():129-32. PubMed ID: 2129064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
    Juhlin I; Tunevall G
    Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bactericidal kinetics of an in vitro infection model of once-daily ceftriaxone plus amikacin against gram-positive and gram-negative bacteria.
    Scaglione F; Dugnani S; Demartini G; Arcidiacono MM; Cocuzza CE; Fraschini F
    Chemotherapy; 1995; 41(4):239-46. PubMed ID: 7555203
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
    Daschner FD; Steffens A; Langmaack H
    Chemotherapy; 1979; 25(5):282-5. PubMed ID: 113178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Infection with netilmicin resistant Serratia marcescens in a special care baby unit.
    Lewis DA; Hawkey PM; WattsJA ; Speller DC; Primavesi RJ; Fleming PJ; Pitt TL
    Br Med J (Clin Res Ed); 1983 Dec; 287(6406):1701-5. PubMed ID: 6315130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron.
    Ibrahim KH; Gunderson BW; Hermsen ED; Hovde LB; Rotschafer JC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4195-9. PubMed ID: 15504841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A series of clinical study on netilmicin].
    Ji S; Wang R; Wang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jun; 22(6):354-7. PubMed ID: 11775826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of bactericidal activity of cefpirome-aminoglycoside combination against Pseudomonas aeruginosa strains with intermediate sensitivity to cefpirome and in various phenotypes of beta-lactam resistance].
    Canis F; Cavallo JD; Husson MO
    Pathol Biol (Paris); 1997 May; 45(5):420-3. PubMed ID: 9296096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.
    Liu JY; Wang FD; Ho MW; Lee CH; Liu JW; Wang JT; Sheng WH; Hseuh PR; Chang SC
    J Microbiol Immunol Infect; 2016 Dec; 49(6):918-923. PubMed ID: 26364729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The in vivo and in vitro postantibiotic effect of aminoglycosides using a clinically isolated micro-organism.
    Arai S; Kawamura R; Kamiya H; Ishii T; Sakurai M
    Acta Paediatr Jpn; 1993 Feb; 35(1):17-21. PubMed ID: 8460539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Evaluation of bactericidal activity of arbekacin in mixed culture with MRSA and Pseudomonas aeruginosa using an in vitro pharmacokinetic simulation system].
    Tsuji A; Sugano T; Yamaguchi K; Goto S; Takada T; Takase Y; Yoshida T
    Jpn J Antibiot; 1994 Jun; 47(6):655-63. PubMed ID: 8072174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of subinhibitory levels of aminoglycosides and fluoroquinolines on hydrophobicity and motility of Serratia marcescens].
    Majtán V; Majtánová L
    Epidemiol Mikrobiol Imunol; 2001 Feb; 50(1):26-30. PubMed ID: 11233670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.